1. Early development of de novo hepatocellular carcinoma after direct‐acting agent therapy: Comparison with pegylated interferon‐based therapy in chronic hepatitis C patients. Issue 10 (17th May 2018) Authors: Yoo, S. H.; Kwon, J. H.; Nam, S. W.; Kim, H. Y.; Kim, C. W.; You, C. R.; Choi, S. W.; Cho, S. H.; Han, J.‐Y.; Song, D. S.; Chang, U. I.; Yang, J. M.; Lee, H. L.; Lee, S. W.; Han, N. I.; Kim, S.‐H.; Song, M. J.; Hwang, S.; Sung, P. S.; Jang, J. W. Journal: Journal of viral hepatitis Issue: Volume 25:Issue 10(2018) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Modelling the Effect of a Novel Autodissemination Trap on the Spread of Dengue in Shah Alam and Malaysia. (4th August 2019) Authors: Liang, Y.; Ahmad Mohiddin, M. N.; Bahauddin, R.; Hidayatul, F. O.; Nazni, W. A.; Lee, H. L.; Greenhalgh, D. Other Names: Blyuss Konstantin Academic Editor. Journal: Computational and mathematical methods in medicine Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Synthesis and Characterizations of Bare CdS Nanocrystals Using Chemical Precipitation Method for Photoluminescence Application. (8th December 2009) Authors: Lee, H. L.; Issam, A. M.; Belmahi, M.; Assouar, M. B.; Rinnert, H.; Alnot, M. Other Names: Obare Sherine Academic Editor. Journal: Journal of nanomaterials Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Synthesis and Characterizations of Bare CdS Nanocrystals Using Chemical Precipitation Method for Photoluminescence Application. (8th December 2009) Authors: Lee, H. L.; Issam, A. M.; Belmahi, M.; Assouar, M. B.; Rinnert, H.; Alnot, M. Other Names: Obare Sherine Academic Editor. Journal: Journal of nanomaterials Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked?. (14th July 2021) Authors: Steele, L.; Lee, H. L.; Maruthappu, T.; O'Toole, E. A. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 7(2021) Page Start: 1290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked?. (1st October 2021) Authors: Steele, L.; Lee, H. L.; Maruthappu, T.; O'Toole, E. A. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 7(2021) Page Start: 1290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Who writes dermatology randomized controlled trials? The need to specify the role of medical writers. (1st August 2021) Authors: Steele, L.; Lee, H. L.; Earp, E.; Hong, A.; Thomson, J. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 6(2021) Page Start: 1086 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Who writes dermatology randomized controlled trials? The need to specify the role of medical writers. (4th June 2021) Authors: Steele, L.; Lee, H. L.; Earp, E.; Hong, A.; Thomson, J. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 6(2021) Page Start: 1086 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗